GABAPENTIN
| Brand name | GABAPENTIN |
|---|---|
| Active ingredient | GABAPENTIN |
| Strength | 250MG/5ML |
| Dosage form | SOLUTION |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | February 2011 |
| Marketing status | RX |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.